Recent Finacing
Recent Raise
HealthBio develops AI-driven diagnostics and a maraviroc/atorvastatin therapeutic protocol targeting vascular inflammation and Long COVID, holding a CCR5 patent, treating patients commercially and initiating a Phase III trial.